Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Outlook Therapeutics (OTLK) over the last 3 years, with Q4 2025 value amounting to -$1.4 million.

  • Outlook Therapeutics' Change in Receivables changed N/A to -$1.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.1 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2025, which is N/A changed from last year.
  • Per Outlook Therapeutics' latest filing, its Change in Receivables stood at -$1.4 million for Q4 2025.
  • Over the past 5 years, Outlook Therapeutics' Change in Receivables peaked at -$260491.0 during Q3 2025, and registered a low of -$1.4 million during Q4 2025.